Avidity Biosciences
RNA
#1831
Rank
โ‚ฌ9.24 B
Marketcap
61,38ย โ‚ฌ
Share price
-0.06%
Change (1 day)
70.15%
Change (1 year)

Revenue for Avidity Biosciences (RNA)

Revenue in 2025 (TTM): โ‚ฌ18.2 Million

According to Avidity Biosciences's latest financial reports the company's current revenue (TTM ) is โ‚ฌ17.9 Million. In 2024 the company made a revenue of โ‚ฌ10.47 Million an increase over the revenue in the year 2023 that were of โ‚ฌ8.64 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avidity Biosciences from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ18.2 M73.84%
2024 โ‚ฌ10.47 M21.09%
2023 โ‚ฌ8.64 M0.57%
2022 โ‚ฌ8.59 M4.42%
2021 โ‚ฌ8.23 M49.24%
2020 โ‚ฌ5.51 M166.55%
2019 โ‚ฌ2.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
PTC Therapeutics
PTCT
โ‚ฌ1.52 B 8,425.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ99.23 M 454.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.07 B 11,466.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.49 B 2,670.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚ฌ6.12 M-65.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚ฌ96.75 M 440.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.87 B 300,772.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.33 B 202,855.61%๐Ÿ‡ฌ๐Ÿ‡ง UK